Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Hematology Analyzer Evaluated for Reliability and Efficiency

By LabMedica International staff writers
Posted on 10 Dec 2012
A high throughput hematology analyzer is found to be reliable, efficient, as well as highly user-friendly and ergonomically designed. More...


A recently introduced series of hematology analyzers are able to carry out complete blood count (CBC), eight-part differential, reticulocyte and erythroblast analysis, as well as body fluids measurements (CBF).

Hematologists at St-Joseph St-Luc Hospital (Lyon, France) evaluated the Pentra DX Nexus analyzers, which offer 50 parameters and a high throughput of 120 samples per hour. The study used the XE-2100 (Sysmex; Kobe, Japan) as a reference system to compare the functions and ergonomics of the workcell. This consisted of a Pentra DX Nexus analyzer, SPS evolution slide maker/stainer and ABX Pentra ML data management system (HORIBA Medical; Northampton, UK).

The results of the evaluations show the instrument’s performance to be very good and the system offers significant improvements over previous generations of the Pentra analyzers for both traceability and ergonomics. The stability and precision functional evaluation of the results demonstrated that the technical abilities of the analyzer fulfilled stringent medical requirements and the manufacturer’s specifications.

A significant improvement in the new Pentra DX Nexus model is the color touch screen that uses easily identifiable icons to denote different functions of the analyzer. The virtual keyboard was found by the study participants to be more useful than a physical keyboard for entering data. Transferring data and hardware connections have also been made easier by multiple USB ports. In addition, a new laser source dissipates less heat and reduces the power requirements and noise generated by the instrument. The study found that the reduced size of the analyzer was also a positive attribute for laboratories, where space is of a premium.

Cleve Wright, General Manager of HORIBA Medical said, “With its new color touch screen and smart access to various functionalities, the Pentra Nexus is an exciting addition to our broad range of Pentra hematology analyzers. All are designed to meet our many differing customer requirements, both in the laboratory and at the point-of-care.”

Related Links:

St-Joseph St-Luc Hospital
Sysmex
HORIBA Medical



New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.